AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on U.S. investments
By Maggie Fick and Yadarisa Shabong (Reuters) -Drugmaker AstraZeneca (NASDAQ:AZN) lifted its annual sales and profit forecast for the second time this year
By Maggie Fick and Yadarisa Shabong (Reuters) -Drugmaker AstraZeneca (NASDAQ:AZN) lifted its annual sales and profit forecast for the second time this year
Investing.com — Shares of Bayer (ETR:BAYGN) fell over 11% on Tuesday following disappointing Q3 results and a reduction in the company’s EBITDA
Investing.com — UBS analysts said they remain bullish ahead of Nvidia’s earnings report next week, expecting the AI darling to deliver strong
By Stephanie van den Berg AMSTERDAM (Reuters) -A Dutch court on Tuesday accepted Shell (LON:SHEL)’s appeal against a landmark climate ruling, dismissing the
(Reuters) – Avia Solutions Group, which leases aircraft and provides related services, has ordered 40 Boeing (NYSE:BA) 737 Max 8 jets, with
Investing.com – The U.S. dollar rose Tuesday to a four-month high as traders continued to position for the new Trump administration and
Investing.com – The UK unemployment rate increased by more than expected in September, data showed Tuesday, piling the pressure on the Bank
BANGKOK (Reuters) – Thailand’s cabinet approved soft loans worth 55 billion baht ($1.58 billion) to boost the property sector, a deputy finance
FRANKFURT (Reuters) – Bayer (OTC:BAYRY) on Tuesday lowered its full-year operating earnings guidance, citing weaker agricultural markets in Latin America. The German group
By Kantaro Komiya TOKYO (Reuters) -Nissan Motor shares jumped as much as almost 21% on Tuesday after a filing showed activist investor Effissimo